Cell based therapy for the management of chronic pain
- PMID: 21359073
- PMCID: PMC3040428
- DOI: 10.4097/kjae.2011.60.1.3
Cell based therapy for the management of chronic pain
Abstract
The management of chronic pain, particularly neuropathic pain, still has significant unmet needs. In addition to inadequate symptomatic relief, there are concerns about adverse effects and addiction associated with treatments. The transplantation of cells that secrete neuroactive substances with analgesic properties into the central nervous system has only become of practical interest in more recent years, but provides a novel strategy to challenge current approaches in treating chronic pain. This review covers pre-clinical and clinical studies from both allogeneic and xenogeneic sources for management of chronic refractory pain.
Keywords: Cell therapy; Chronic pain; Encapsulated cells; Gene therapy; Genetically modified cells.
References
-
- Pruimboom L, van Dam AC. Chronic pain: a non-use disease. Med Hypotheses. 2007;68:506–511. - PubMed
-
- Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA. 1998;280:147–151. - PubMed
-
- Siegan JB, Sagen J. Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain. 1997;70:279–285. - PubMed
-
- Baek WY, Kim HG, Kim YM, Lim JO, Jeon YH. Microencapsulated bovine adrenal medullary chromaffin cells transplanted into rat spinal cord alleviated cold allodynia. Korean J Anesthesiol. 2004;46:354–359.
LinkOut - more resources
Full Text Sources